Skip to main content

EQT Fund Management S.a r.l.

13F filer · CIK 0001834239
Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$863MU.S. long equity reported on 13F
Positions50 new · 0 closed
Net flow last quarter+$19.3MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 20265 positions
WAYWaystar Holding Corp.$511M59.21%12.96%Not reportedQ3 2025
PHVSPharvaris N.V.$118M13.73%5.25%Not reportedQ3 2025
OCSOculis Holding AG$96.4M11.18%Not reported+17.8%Q3 2025
EVMNEvommune, Inc.$70.3M8.15%14.58%+7.3%Q4 2025
AGMBAgomab Therapeutics NV$66.7M7.74%15.05%Not reportedQ1 2026
Q1 2026Reported May 14, 20265 positions
WAYWaystar Holding Corp.$600M58.77%12.98%Not reportedQ3 2025
OCSOculis Holding AG$157M15.37%Not reportedNot reportedQ3 2025
EVMNEvommune, Inc.$113M11.10%13.69%Not reportedQ4 2025
PHVSPharvaris N.V.$96.7M9.48%5.25%Not reportedQ3 2025
AGMBAgomab Therapeutics NV$53.9M5.28%15.05%NewQ1 2026
Q4 2025Reported Feb 11, 20264 positions
WAYWaystar Holding Corp.$815M73.27%12.99%Not reportedQ3 2025
OCSOculis Holding AG$118M10.60%Not reportedNot reportedQ3 2025
PHVSPharvaris N.V.$95M8.55%5.25%Not reportedQ3 2025
EVMNEvommune, Inc.$84.4M7.59%15.64%NewQ4 2025
Q3 2025Reported Nov 14, 20254 positions
WAYWaystar Holding Corp.$943M50.63%14.24%NewQ3 2025
KGSKodiak Gas Services, Inc.$731M39.21%22.79%NewQ3 2025
OCSOculis Holding AG$104M5.57%Not reportedNewQ3 2025
PHVSPharvaris N.V.$85.4M4.59%6.30%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.